|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95.67 USD | -0.03% |
|
-9.21% | +20.55% |
| 08-07 | DA Davidson Adjusts Price Target on CVS Health to $120 From $100, Maintains Buy Rating | MT |
| 08-06 | Barclays Adjusts Price Target on CVS Health to $108 From $106 | MT |
| Market Cap | 122B 106B 99.01B 90.49B 171B 11,670B 173B 1,161B 456B 5,838B 459B 449B 19,444B | P/E 2026 * |
14.1x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 175B 151B 142B 129B 244B 16,678B 248B 1,659B 651B 8,344B 657B 642B 27,789B | EV / Sales 2026 * |
0.42x | EV / Sales 2027 * | 0.4x |
| Free-Float |
71.17% | Yield 2026 * |
2.78% | Yield 2027 * | 2.86% |
Last Transcript: CVS Health Corporation
| 1 day | -0.03% | ||
| 1 week | -9.21% | ||
| Current month | -8.39% | ||
| 1 month | -8.14% | ||
| 3 months | +5.65% | ||
| 6 months | +26.38% | ||
| Current year | +20.55% |
| 1 week | 93.5 |  | 101 |
| 1 month | 93.5 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 64.32 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.03% | -9.21% | +45.97% | +29.35% | 122B | |
| +0.16% | +1.82% | +8.50% | +54.46% | 89.64B | |
| -0.32% | +4.78% | +7.25% | +57.10% | 30.52B | |
| -0.30% | +2.45% | +34.28% | +77.18% | 26.23B | |
| +0.13% | -2.27% | -11.89% | -12.75% | 21.68B | |
| -0.84% | +3.98% | +56.98% | +251.87% | 20.93B | |
| +0.62% | -5.68% | +2.82% | -11.73% | 12.95B | |
| -0.04% | -21.39% | +41.85% | +69.41% | 11.71B | |
| -1.87% | -1.83% | -14.02% | +99.55% | 10.92B | |
| -0.46% | +2.19% | +0.26% | +31.49% | 10.18B | |
| Average | -0.14% | -1.21% | +17.20% | +64.59% | 35.71B | |
| Weighted average by Cap. | -0.06% | -1.91% | +24.69% | +54.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 417B 361B 338B 309B 582B 39,815B 591B 3,961B 1,554B 19,918B 1,568B 1,533B 66,339B | 429B 371B 347B 317B 598B 40,920B 607B 4,071B 1,597B 20,471B 1,611B 1,576B 68,180B |
| Net income | 8.71B 7.54B 7.05B 6.44B 12.14B 831B 12.33B 82.69B 32.45B 416B 32.72B 32.01B 1,385B | 9.05B 7.83B 7.32B 6.69B 12.61B 863B 12.81B 85.86B 33.69B 432B 33.98B 33.23B 1,438B |
| Net Debt | 52.52B 45.46B 42.49B 38.84B 73.19B 5,009B 74.33B 498B 196B 2,506B 197B 193B 8,345B | 49.73B 43.05B 40.24B 36.77B 69.3B 4,742B 70.38B 472B 185B 2,373B 187B 183B 7,902B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | US$95.67 | -0.03% | 7,025,233 |
| 26-08-07 | US$95.70 | -0.54% | 12,403,394 |
| 26-08-06 | US$96.22 | -2.93% | 10,583,035 |
| 26-08-05 | US$99.12 | -5.08% | 18,514,644 |
| 26-08-04 | US$104.42 | -0.90% | 7,229,227 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
